查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477929

心臟瓣膜裝置市場 - 按產品類型（機械心臟瓣膜、經​​導管心臟瓣膜、生物心臟瓣膜）、按程序（更換程序、修復程序）、按最終用途 - 2024 - 2032 年全球預測

Heart Valve Devices Market - By Product Type (Mechanical Heart Valves, Transcatheter Heart Valves, Biological Heart Valves), By Procedure (Replacement Procedures, Repair Procedures), By End-use - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 240 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在人口老化、心臟瓣膜設備技術進步以及微創手術需求不斷成長的推動下，心臟瓣膜設備市場規模預計從 2024 年到 2032 年複合年成長率將超過 8.6%。

隨著心血管疾病成為全球死亡的主要原因，迫切需要有效的治療方案來解決這個日益嚴重的健康問題。根據美國心臟病學會的數據，全球因心血管疾病(CVD) 死亡的人數從1990 年的1240 萬人激增至2022 年的1980 萬人。人口老化等因素正在導致全球心血管疾病負擔不斷增加。

隨著心臟瓣膜疾病、冠狀動脈疾病和心臟衰竭等疾病的發病率持續上升，對包括心臟瓣膜裝置在內的先進醫療干預措施的需求預計將大幅增加。這一趨勢在已開發國家和發展中國家都很明顯，這些國家的醫療保健系統正在努力滿足心血管疾病患者日益成長的需求。因此，不斷擴大的患者群體和不斷成長的治療選擇需求迫使製造商專注於開發創新解決方案，以應對不斷變化的醫療保健環境。

心臟瓣膜裝置市場根據產品類型、程序、最終用途和地區進行分類。

按產品類型分類，從2024 年到2032 年，經導管心臟瓣膜產品領域的行業規模預計將以8.9% 的複合年成長率成長。的替代方案，使患者能夠以更少的成本接受瓣膜置換手術。這種創新方法也贏得了患者和醫療保健提供者的廣泛接受，推動了該細分市場的成長。

到2032 年，修復手術領域的心臟瓣膜裝置產業將以8.7% 的成長率大幅擴張。風險以及提高患者品質的生活。因此，人們對開發和採用修復技術來治療瓣膜性心臟病越來越感興趣。

在心血管疾病盛行率上升、醫療基礎設施改善和醫療支出增加的推動下，亞太地區心臟瓣膜裝置產業規模預計在 2024 年至 2032 年期間複合年成長率將達到創紀錄的 9.8%。在人口變化、生活方式因素和心血管健康意識不斷增強的推動下，中國、印度和日本等國家對心臟介入的需求正在激增。此外，旨在擴大醫療保健服務範圍和促進醫療旅遊的政府措施進一步促進了該地區的市場成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心血管疾病盛行率增加
      • 技術進步
      • 政府措施和資金支持
      • 對微創手術的偏好不斷上升
    • 產業陷阱與挑戰
      • 嚴格的法規核准流程
      • 潛在的併發症和不良事件
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析
  • 2023 年定價分析
  • 報銷場景
  • 監管環境
  • 技術景觀
  • 未來市場趨勢

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

  • 主要趨勢
  • 機械心臟瓣膜
    • 主動脈瓣
    • 二尖瓣
  • 經導管心臟瓣膜
    • 主動脈瓣
    • 二尖瓣
    • 肺動脈瓣
    • 三尖瓣
  • 生物心臟瓣膜
    • 主動脈瓣
    • 二尖瓣

第 6 章：市場估計與預測：按程序，2018 年 - 2032 年

  • 主要趨勢
  • 更換程序
    • 主動脈瓣置換手術 (SAVR)
    • 經導管主動脈瓣置換術 (TAVR)
    • 經導管二尖瓣置換術 (TMVR)
    • 其他更換程序
  • 維修程序
    • 經導管二尖瓣修復術 (TMVr)
    • 經導管三尖瓣修復術 (TTVR)
    • 瓣膜成形術
    • 其他維修程序

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 心導管實驗室
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Abbott Laboratories
  • Artivion, Inc
  • Boston Scientific Corporation
  • Colibri Heart Valve
  • Edwards Lifesciences Corporation
  • JenaValve
  • LivaNova PLC
  • Medtronic plc
  • Symetis
  • TTK Healthcare Limited
簡介目錄
Product Code: 8299

Heart Valve Devices Market size is expected to garner more than 8.6% CAGR from 2024-2032, driven by growing aging population, technological advancements in heart valve devices, and the rising demand for minimally invasive procedures.

With cardiovascular diseases emerging as a leading cause of mortality worldwide, there is a pressing need for effective treatment options to address this growing health concern. According to American College of Cardiology, global deaths attributed to cardiovascular diseases (CVD) surged from 12.4 million in 1990 to 19.8 million in 2022. Factors, such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, and the aging population are contributing to the escalating burden of cardiovascular diseases globally.

As the incidence of conditions like heart valve disorders, coronary artery disease, and heart failure continues to rise, the demand for advanced medical interventions, including heart valve devices, is expected to increase substantially. This trend is evident in both developed and developing countries, where healthcare systems are striving to meet the growing needs of patients with cardiovascular ailments. Consequently, the expanding patient pool and the rising demand for treatment options are compelling manufacturers to focus on developing innovative solutions to address the evolving healthcare landscape.

The heart valve devices market is classified based on product type, procedure, end-use and region.

By product type, the industry size from the transcatheter heart valves product segment is expected to grow at 8.9% CAGR from 2024 to 2032. These valves offer a less invasive alternative to traditional open-heart surgeries, enabling patients to undergo valve replacement procedures with reduced post-operative complications and shorter recovery times. This innovative approach has also garnered widespread acceptance among both patients and healthcare providers, driving the segment growth.

Heart valve devices industry from the repair procedures segment will expand significantly at 8.7% growth rate through 2032. Repair procedures offer several advantages over valve replacement, including better preservation of cardiac anatomy and function, reduced risk of long-term complications, and improved patient quality of life. As a result, there is growing interest in the development and adoption of repair techniques for the management of valvular heart diseases.

Asia Pacific heart valve devices industry size is set to record 9.8% CAGR between 2024 and 2032, driven by the rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and increasing healthcare expenditure. Countries, such as China, India, and Japan are witnessing a surge in demand for cardiac interventions, driven by demographic changes, lifestyle factors, and increasing awareness about cardiovascular health. Moreover, government initiatives aimed at expanding access to healthcare services and promoting medical tourism are further contributing to market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Government initiatives and funding support
      • 3.2.1.4 Rising preference for minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory approval processes
      • 3.2.2.2 Potential complications and adverse events
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Pricing analysis, 2023
  • 3.7 Reimbursement scenario
  • 3.8 Regulatory landscape
  • 3.9 Technological landscape
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Mechanical heart valves
    • 5.2.1 Aortic valve
    • 5.2.2 Mital valve
  • 5.3 Transcatheter heart valves
    • 5.3.1 Aortic valve
    • 5.3.2 Mital valve
    • 5.3.3 Pulmonary valve
    • 5.3.4 Tricuspid valve
  • 5.4 Biological heart valves
    • 5.4.1 Aortic valve
    • 5.4.2 Mital valve

Chapter 6 Market Estimates and Forecast, By Procedure, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Replacement procedures
    • 6.2.1 Surgical aortic valve replacement (SAVR)
    • 6.2.2 Transcatheter aortic valve replacement (TAVR)
    • 6.2.3 Transcatheter mitral valve replacement (TMVR)
    • 6.2.4 Other replacement procedures
  • 6.3 Repair procedures
    • 6.3.1 Transcatheter mitral valve repair (TMVr)
    • 6.3.2 Transcatheter tricuspid valve repair (TTVr)
    • 6.3.3 Valvuloplasty
    • 6.3.4 Other repair procedures

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Cardiac catheterization labs
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Artivion, Inc
  • 9.3 Boston Scientific Corporation
  • 9.4 Colibri Heart Valve
  • 9.5 Edwards Lifesciences Corporation
  • 9.6 JenaValve
  • 9.7 LivaNova PLC
  • 9.8 Medtronic plc
  • 9.9 Symetis
  • 9.10 TTK Healthcare Limited